Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | F2RL3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | COPS7B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | ADAM19 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | ITIH2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | ZNF683 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | UCP3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | PTRH1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | FAM171B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | XKR7 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | TIMP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |